IL17A and Alzheimer disease: Although the well-established role of IL-17 in AD, differences may be present in elderly patients due to factors such as immune-senescence (age-related changes in the immune system), alterations in skin barrier function associated with aging, comorbidities, and comorbidities systemic treatments.